TAP2 NM_001290043.2(TAP2):c.608+8G>A

CI-VAR-00196147Explore in graph →NM_001290043.2:c.608+8G>AClinVar 1168814 rs2071467

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
1168814	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	2	MHC class I deficiency; TAP2-related disorder; Acute myeloid leukemia; Malignant lymphoma, large B-cell, diffuse; Thymoma; Uterine corpus endometrial carcinoma; Uterine carcinosarcoma; Cholangiocarcinoma	germline	5	Feb 04, 2026	clinvar